Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study

Peer Review reports

Original Submission
24 Oct 2018	Submitted	Original manuscript
15 Dec 2018	Reviewed	Reviewer Report - Anand Dubey
17 Dec 2018	Reviewed	Reviewer Report - Tetsushi Yoshikawa
30 Jan 2019	Author responded	Author comments - Saul N Faust
Resubmission - Version 2
30 Jan 2019	Submitted	Manuscript version 2
Publishing
31 Jan 2019	Editorially accepted
7 Feb 2019	Article published	10.1186/s12887-019-1425-7

Back to article page